Superseded public profile

In clinical trials↗Metabolic↗

Superseded · version 2: Survodutide↗

Related names recorded in this version: BI 456906↗

A glucagon/GLP-1 receptor agonist candidate. This profile cites a ClinicalTrials.gov study record that was active, not recruiting.↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 27, 2026

We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change. 1

What this version reported

ClinicalTrials.gov lists a Boehringer Ingelheim study as active, not recruiting, updated July 22, 2026.↗

Organizations named in cited records:
  • Boehringer Ingelheim↗

Trial records: NCT05202353

Sources for this version

  1. 1
    BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver · record history version 50 · last update posted 2026-07-22 ↗

    ClinicalTrials.gov · Official source · Source checked July 22, 2026